S?n ph?m Ago Tumor ???c ch? ??nh s? d?ng cho ph? n? trong các tr??ng h?p sau ?ây:carriers may very well be improved candidates for therapy with one-agent PARP inhibitors than triple-negative breast most cancers BRCA1Exceptional aspect effect administration and supportive care are important contributors to the overall hazard/advantage equilibrium